SCHEMBL485221

SCHEMBL485221

O=C(O)N1CCC2(CCN(c3ccc(C(F)(F)F)cn3)CC2)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.54
LMNA P02545 6/20 0.54
HTT P42858 5/20 0.54
MAPT P10636 4/20 0.54
KDM4E B2RXH2 6/20 0.53
ABL1 P00519 1/20 0.53
HPGD P15428 1/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.51
DPP4 P27487 1/20 0.51
DPP8 Q6V1X1 1/20 0.51
DPP7 Q9UHL4 1/20 0.51
ADAM10 O14672 1/20 0.50
MMP1 P03956 1/20 0.50
MMP2 P08253 1/20 0.50
MMP3 P08254 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484575 0.84 USP2 (0.52) SMN1; SMN2MEN1KMT2ACYP1A2CYP2C9
SCHEMBL3903304 0.83 LMNA (0.69) SMN1; SMN2LMNAHTTMAPTKDM4E
SCHEMBL484535 0.81 CYP3A4 (0.55) HPGDCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL14996519 0.80 MAPT (0.49) SMN1; SMN2LMNAMAPTKDM4EABL1
SCHEMBL31381207 0.80 KDM4E (0.57) SMN1; SMN2LMNAHTTMAPTKDM4E
SCHEMBL30328491 0.79 SMN1; SMN2 (0.60) SMN1; SMN2LMNAHTTMAPTKDM4E
SCHEMBL3074677 0.79 KDM4E (0.71) SMN1; SMN2LMNAHTTMAPTKDM4E
SCHEMBL21853959 0.78 PANK3 (0.48) DPP4
SCHEMBL3729563 0.78 KDM4E (0.53) SMN1; SMN2LMNAHTTMAPTKDM4E
SCHEMBL13131034 0.78 MAPT (0.48) SMN1; SMN2LMNAMAPTKDM4EABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN SMN1; SMN2 3545/4885LMNA 1187/4885HTT 3621/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN SMN1; SMN2 3545/4885LMNA 1187/4885HTT 3621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.